Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Panel
borderColor#ccc
bgColor#D8D8D8
titleBGColor#D0D0D0
borderStylesolid
titleTable of Contents
Table of Contents

...

Panel
borderColor#CCFFFF
bgColor#CCFFFF
titleBGColor#99FFFF
borderStylesolid

Rules Based on Patient's Age

For males and females:

  • If a patient is < 27 years old, follow the Immunization Series and Selection Rules (listed below).
  • If a patient is >= 27 years and < 46 years old and:
    • Has one or more doses at < 46 years old
and
    • , has not completed the series,
then
    • and will be < 46 years old at the next recommended due date, then recommend based on table rules. 
    • Does NOT have any doses at < 46 years old, then Recommendation is Conditional and the reason code is CLINICAL_PATIENT_DISCRETION.
    • Shots administered to a patient who is >= 27 years and < 46 years will continue to be evaluated (based on minimum intervals) and, if valid, will count toward completion of the series.
  • If the patient is >= 46 years old, (or will be >= 46 years old
, then
  • at the next recommended due date), then:
    • Recommendation is Not Recommended and the reason code is TOO_OLD. 
    • If a dose is administered at >= 46 years, the Evaluation is Accepted and the reason code is ABOVE_REC_AGE_SERIES.
    • The series can NOT be initiated and completed once the patient is >= 46 years old.

Rules for Recommending at the CVX Code vs. Vaccine Group Level

  • When recommending in the HPV 3-dose series or HPV 2-dose series, always recommend at the vaccine group level.

...

Dose

Series Name

Absolute Minimum
 Age

Minimum Age

Routine
Age 

Latest Recommended Age (less than)

Valid CVX Code(s)

per Dose for this Series

Invalid CVX Code(s)

per Dose for this Series

1

HPV 2-dose

9 years - 4 days

9 years

11 years

13 years + 4 weeks62, 118, 137, 165

N/A

2

HPV 2-dose

N/A

N/A

N/A

N/A62, 118, 137, 165
N/A

...